COVID stocks are back in the spotlight for next week. MRNA may be a possible long on break above $66.79, where volume resistance decreases . $70-$72 looks like a nice short term target. PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
MRNA, though in the race to provide Covid-19 vaccine, is great for long-term stake. If the vaccine works, mrkt cap could surge to 300bi. If it doesnt, then the company will return to R&D on numerous other cures. Could be the apple of biotech in the sense that if their science works, which just might, then they could cure everything. Could be the first trillion dollar company. Id say in for the long haul but wait for price to dip or buy if, for any reason, stock takes a hit from inability to make covid vaccine.